Media headlines about Calyxt (NASDAQ:CLXT) have trended somewhat positive this week, Accern reports. Accern identifies negative and positive news coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Calyxt earned a news impact score of 0.21 on Accern’s scale. Accern also assigned headlines about the company an impact score of 40.9021770936471 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
Several equities analysts have recently issued reports on CLXT shares. Zacks Investment Research cut shares of Calyxt from a “hold” rating to a “sell” rating in a research note on Tuesday, January 2nd. Citigroup lowered their price objective on shares of Calyxt from $27.00 to $22.00 and set a “neutral” rating on the stock in a research note on Thursday, November 16th. Ladenburg Thalmann Financial Services started coverage on shares of Calyxt in a research note on Wednesday, December 20th. They issued a “buy” rating and a $34.25 price objective on the stock. Jefferies Group reaffirmed a “buy” rating and issued a $27.00 price objective on shares of Calyxt in a research note on Thursday, March 1st. Finally, ValuEngine cut shares of Calyxt from a “hold” rating to a “sell” rating in a research note on Wednesday, March 7th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and four have given a buy rating to the stock. The company has an average rating of “Hold” and an average target price of $29.05.
Shares of Calyxt (NASDAQ CLXT) traded down $0.32 on Tuesday, hitting $18.78. 40,553 shares of the stock traded hands, compared to its average volume of 53,809. The company has a debt-to-equity ratio of 0.13, a quick ratio of 12.41 and a current ratio of 12.41. Calyxt has a 12 month low of $9.26 and a 12 month high of $31.89.
COPYRIGHT VIOLATION NOTICE: This report was posted by BBNS and is the sole property of of BBNS. If you are accessing this report on another website, it was illegally stolen and republished in violation of international copyright laws. The correct version of this report can be read at https://baseballnewssource.com/2018/03/13/calyxt-clxt-earns-news-impact-score-of-0-21/2024848.html.
Calyxt, Inc is a food and agriculture company. The Company is focused on delivering healthier specialty food ingredients, such as healthier oils and high fiber wheat, for consumers and agriculturally advantageous crop traits, such as herbicide tolerance to farmers. The Company also combines gene-editing technology and technical that enables to edit a plant genome to elicit the desired traits and characteristics.
Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.